|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 622 JPY | -3.57% |
|
-2.51% | +19.39% |
| 04-09 | Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023. | CI |
| 03-25 | BioVaxys Technology Plans Private Placement; Down 5.9% | MT |
IMV Corporation reported earnings results for the full year ended September 30, 2023. For the full year, the company reported sales was JPY 13,868 million. Net income was JPY 1,126 million.
Basic earnings per share from continuing operations was JPY 69.11.
| 1st Jan change | Capi. | |
|---|---|---|
| +19.39% | 66.84M | |
| +11.87% | 34.67B | |
| +24.06% | 8.27B | |
| +11.40% | 7.96B | |
| +28.08% | 5.71B | |
| +42.57% | 4.19B | |
| -3.15% | 4.08B | |
| +11.10% | 3.62B | |
| +8.96% | 3.54B | |
| -4.77% | 2.82B |
IMV CORPORATION 
